The pathogenesis of insulin resistance: integrating signaling pathways and substrate flux
Open accessThe DOI matches its Crossref record; 131 of the 131 references it cites were found in a registry or an index.
Abstract
Insulin resistance arises when the nutrient storage pathways evolved to maximize efficient energy utilization are exposed to chronic energy surplus. Ectopic lipid accumulation in liver and skeletal muscle triggers pathways that impair insulin signaling, leading to reduced muscle glucose uptake and decreased hepatic glycogen synthesis. Muscle insulin resistance, due to ectopic lipid, precedes liver insulin resistance and diverts ingested glucose to the liver, resulting in increased hepatic de novo lipogenesis and hyperlipidemia. Subsequent macrophage infiltration into white adipose tissue (WAT) leads to increased lipolysis, which further increases hepatic triglyceride synthesis and hyperlipidemia due to increased fatty acid esterification. Macrophage-induced WAT lipolysis also stimulates hepatic gluconeogenesis, promoting fasting and postprandial hyperglycemia through increased fatty acid delivery to the liver, which results in increased hepatic acetyl-CoA content, a potent activator of pyruvate carboxylase, and increased glycerol conversion to glucose. These substrate-regulated processes are mostly independent of insulin signaling in the liver but are dependent on insulin signaling in WAT, which becomes defective with inflammation. Therapies that decrease ectopic lipid storage and diminish macrophage-induced WAT lipolysis will reverse the root causes of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [99]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In both animal models and human patients, obesity‐induced hyperlipidaemia and lipotoxicity‐induced inflammation is thought to be one of the drivers for SO.[ 63 ]”
From Pathogenesis of sarcopenia and the relationship with fat mass: descriptive review (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In lipid infusion experiments, DAG content in the muscle increases, and consequently PKCθ is activated, resulting in limited phosphorylation of IRS-1 and glucose uptake through GLUT4 [9].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
In the citing paper
“Insulin resistance is the core mechanism of sarcopenic obesity and is also associated with variable cardiometabolic diseases such as cardiovascular disease, type 2 diabetes mellitus, and non-alcoholic fatty liver disease.”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundThe metabolic phenotype in obesity: Fat mass, body fat distribution, and adipose tissue function
Goossens, G. H. (2017) · Obesity Facts · doi:10.1159/000471488 · Cited by 8,481
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760 · cited 1×
“Activated adipose tissue macrophages (ATMs) are recruited via chemokine signaling (96, 97) and release cytokines that promote lipolysis.”
BackgroundLippa, N. C., & Sanderson, S. C. (2013) · Human Heredity · doi:10.1159/000353712 · Cited by 6,078
Adipose Tissue as an Endocrine Organ
Kershaw, E. E., & Flier, J. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-0395 · Cited by 5,522
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“Over a half century ago, Randle and colleagues concluded that muscle insulin resistance associated with obesity could be attributed to increased fatty acid oxidation that limits insulin-stimulated glucose utilization (43).”
BackgroundGenetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
Romeo, S., Kozlitina, J., Xing, C., Pertsemlidis, A., Cox, D., Pennacchio, L. A., Boerwinkle, E., Cohen, J. C., & Hobbs, H. H. (2008) · Nature Genetics · doi:10.1038/ng.257 · Cited by 3,416 · cited 1×
“A common single nucleotide polymorphism (rs738409, I48M) in the lipid droplet protein patatin-like phospholipase domaincontaining protein 3 (PNPLA3, also called adiponutrin) has been associated with increased hepatic steatosis but not insulin resistance (74).”
BackgroundKim, H. J., Park, S. Y., Choi, Y. J., Han, S. J., Lee, K. W., & Kim, D. J. (2013) · Hormone Research in Paediatrics · doi:10.1159/000348848 · Cited by 3,048
Defining the role of mTOR in cancer
Guertin, D. A., & Sabatini, D. M. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.05.008 · Cited by 2,833 · cited 1×
“Insulin activates the insulin receptor tyrosine kinase (IRTK), with subsequent activation of kinases including 3-phosphoinositide-dependent kinase-1 (PDK1) and mTORC2 (6), which converge on Akt phosphorylation (6–8).”
BackgroundAlessi, D. R., James, S. R., Downes, C. P., Holmes, A. B., Gaffney, P. R. J., Reese, C. B., & Cohen, P. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00122-9 · Cited by 2,826
Research works printed but not linked: 3
- 10.1210/jcem.87.8.8761 · doi:10.1210/jcem.87.8.8761 · Paper page
- Kersten, 2014, Physiological regulation of lipoprotein lipase, Biochim Biophys Acta, 1841, 919, 10.1016/j.bbalip.2014.03.013 · DOI · Paper page
- 10.1172/JCI10294 · DOI · Paper page
Cited by
Items 101–200 of 998
Computed Tomography-Derived Myosteatosis and Metabolic Disorders
Miljkovic, I., Vella, C. A., & Allison, M. (2021) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2020.0277 · Cited by 129
“As a major site of insulin-stimulated glucose disposal, skeletal muscle plays a key role in the control of blood glucose levels, as well as type 2 diabetes mellitus (T2DM) risk [11,12].”
BackgroundBourebaba, L., & Marycz, K. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8122033 · Cited by 136
The diagnosis and treatment of PCOS in adolescents: an update
Witchel, S. F., Burghard, A. C., Tao, R. H., & Oberfield, S. E. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000778 · Cited by 119
The Role of the Nrf2 Signaling in Obesity and Insulin Resistance
Li, S., Eguchi, N., Lau, H., & Ichii, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186973 · Cited by 115
da Silva Rosa, S. C., Martens, M. D., Field, J. T., Nguyen, L., Kereliuk, S. M., Hai, Y., Chapman, D., Diehl-Jones, W., Aliani, M., West, A. R., et al. (2021) · Autophagy · doi:10.1080/15548627.2020.1821548 · Cited by 117
“Lipid infusion studies in humans, and high-fat feeding in rodents have demonstrated that muscle tissue rapidly accumulates diacylglycerols, ceramides, and triglycerides in response to these lipid exposures [1,3].”
BackgroundTorre, S. D. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.572490 · Cited by 143
Sanders, F. W. B., Acharjee, A., Walker, C., Marney, L., Roberts, L. D., Imamura, F., Jenkins, B., Case, J., Ray, S., Virtue, S., et al. (2018) · Genome Biology · doi:10.1186/s13059-018-1439-8 · Cited by 114
“However, TAGs are synthesised via DAGs and these lipids have been shown to interfere with insulin signalling by activating protein kinase CƐ (PKCƐ) which leads to reduced insulin-stimulated insulin receptor substrate 2 (IRS-2) tyrosine phosphorylation [40, 41].”
BackgroundMizrachi, A., Shamay, Y., Shah, J., Brook, S., Soong, J., Rajasekhar, V. K., Humm, J. L., Healey, J. H., Powell, S. N., Baselga, J. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms14292 · Cited by 113
“Upon systemic treatment with PI3K/AKT inhibitors, hyperglycaemia is induced by phosphorylation of insulin receptor (IR) leading to loss of insulin signalling in peripheral tissue and pancreatic b cells 33,34 .”
Is the calorie concept a real solution to the obesity epidemic?
Camacho, S., & Ruppel, A. (2017) · Global Health Action · doi:10.1080/16549716.2017.1289650 · Cited by 144
Metabolic Changes of Hepatocytes in NAFLD
Lu, Q., Tian, X., Wu, H., Huang, J., Li, M., Mei, Z., Zhou, L., Xie, H., & Zheng, S. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.710420 · Cited by 126
A review of a potential and promising probiotic candidate— Akkermansia muciniphila
Cheng, D., & Xie, M. Z. (2020) · Journal of Applied Microbiology · doi:10.1111/jam.14911 · Cited by 123
“muciniphila supplementation were attributed to the elevated insulin-signalling activation (Samuel and Shulman 2016).”
BackgroundOxytocin in metabolic homeostasis: implications for obesity and diabetes management
Ding, C., Leow, M. K. ‐., & Magkos, F. (2019) · Obesity Reviews · doi:10.1111/obr.12757 · Cited by 111
“Oxytocin-mediated reduction of WAT macrophage infiltration (52) may also remediate obesity-associated lipolysis in WAT and increase hepatic TG synthesis from enhanced fatty acid esterification (51).”
BackgroundInfluentialPrice, N. L., Singh, A. K., Rotllan, N., Goedeke, L., Wing, A., Canfrán-Duque, A., Diaz-Ruiz, A., Araldi, E., Baldán, Á., Camporez, J.-P., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.01.074 · Cited by 110
“Loss of miR-33 Causes Increased Lipid Accumulation in Liver but Does Not Affect Expression of Genes Involved in Hepatic Lipid Synthesis Accumulation of lipids in peripheral tissues can promote insulin resistance (Samuel and Shulman, 2016; Shulman, 2014) and may contribute to the impaired insulin sensitivity of miR-33…”
Self-citationSteneberg, P., Lindahl, E., Dahl, U., Lidh, E., Straseviciene, J., Backlund, F., Kjellkvist, E., Berggren, E., Lundberg, I., Bergqvist, I., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.99114 · Cited by 108
“Increased peripheral glucose disposal will relieve the demand on β cells to produce and secrete insulin, thus indirectly ameliorating β cell stress (7, 8, 17) and, by increasing glucose uptake in skeletal muscle AMPK, may indirectly preserve/restore β cell function.”
BackgroundMeneses, M. J., Silvestre, R. D., Sousa‐Lima, I., & Macedo, M. P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20164049 · Cited by 132
“IR refers to a state where insulin-sensitive cells do not appropriately respond to circulating insulin [16,17].”
BackgroundReversing pancreatic β-cell dedifferentiation in the treatment of type 2 diabetes
Son, J., & Accili, D. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01043-8 · Cited by 134
Taheri, R., Mokhtari, Y., Yousefi, A., & Bashash, D. (2024) · Cell Biology International · doi:10.1002/cbin.12189 · Cited by 126
“Therefore, any defects in the expression or function of enzymes and regulatory proteins that are involved in the insulin signal transduction may result in insulin resistance in peripheral tissues (Samuel & Shulman, 2016; Sesti, 2006).”
Bruinstroop, E., Dalan, R., Cao, Y., Bee, Y. M., Chandran, K., Cho, L. W., Soh, S. B., Teo, E. K., Toh, S.-A., Leow, M. K. S., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00475 · Cited by 108
Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome
Saeedi Borujeni, M. J., Esfandiary, E., Taheripak, G., Codoñer‐Franch, P., Alonso‐Iglesias, E., & Mirzaei, H. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26271 · Cited by 106
Sidibeh, C. O., Pereira, M. J., Abalo, X. M., J. Boersma, G., Skrtic, S., Lundkvist, P., Katsogiannos, P., Hausch, F., Castillejo-López, C., & Eriksson, J. W. (2018) · Endocrine · doi:10.1007/s12020-018-1674-5 · Cited by 104
Striatal dopamine regulates systemic glucose metabolism in humans and mice
ter Horst, K. W., Lammers, N. M., Trinko, R., Opland, D. M., Figee, M., Ackermans, M. T., Booij, J., van den Munckhof, P., Schuurman, P. R., Fliers, E., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aar3752 · Cited by 106
“Whereas genetics, lifestyle, and cellular defects in adipocytes, hepatocytes, and skeletal myocytes have been the focus of study for many years (3), the brain has also emerged as an important regulator of systemic glucose and energy metabolism (4, 5).”
BackgroundKrawczyk, M., Burzyńska-Pędziwiatr, I., Woźniak, L. A., & Bukowiecka‐Matusiak, M. (2023) · Biomolecules · doi:10.3390/biom13091402 · Cited by 139
“Thus, maintaining the proper balance of the redox state is essential in oxidative stress-induced complications and insulin resistance prevention [89].”
BackgroundFGF21-receptor agonists: an emerging therapeutic class for obesity-related diseases
Sonoda, J., Chen, M. Z., & Baruch, A. (2017) · Hormone Molecular Biology and Clinical Investigation · doi:10.1515/hmbci-2017-0002 · Cited by 105
PPARβ/δ: A Key Therapeutic Target in Metabolic Disorders
Palomer, X., Barroso, E., Pizarro‐Delgado, J., Peña, L., Botteri, G., Zarei, M., Aguilar-Recarte, D., Montori-Grau, M., & Vázquez‐Carrera, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030913 · Cited by 118
“Insulin resistance, which is defined as a defect in the ability of insulin to drive glucose into its target tissues, predicts and precedes the development of type 2 diabetes mellitus [44].”
BackgroundStenvers, D. J., Jongejan, A., Atiqi, S., Vreijling, J. P., Limonard, E. J., Endert, E., Baas, F., Moerland, P. D., Fliers, E., Kalsbeek, A., et al. (2019) · Diabetologia · doi:10.1007/s00125-019-4813-5 · Cited by 112
Inactivating hepatic follistatin alleviates hyperglycemia
Tao, R., Wang, C., Stöhr, O., Qiu, W., Hu, Y., Miao, J., Dong, X. C., Leng, S., Stefater, M., Stylopoulos, N., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0048-0 · Cited by 104
Younge, N. E., Newgard, C. B., Cotten, C. M., Goldberg, R. N., Muehlbauer, M. J., Bain, J. R., Stevens, R. D., O’Connell, T. M., Rawls, J. F., Seed, P. C., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-44547-y · Cited by 115
Obesity as the Main Risk Factor for Metabolic Syndrome in Children
Gepstein, V., & Weiss, R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00568 · Cited by 104
“In the context of energy surplus, lipid deposition within insulin responsive tissues, such as liver and muscle, has been shown to negatively affect the glucose related portions of the insulin signal transduction pathway (17).”
BackgroundInfluentialSarcopenia and Diabetes: A Detrimental Liaison of Advancing Age
Lisco, G., Disoteo, O. E., De Tullio, A., De Geronimo, V., Giagulli, V. A., Monzani, F., Jirillo, E., Cozzi, R., Guastamacchia, E., De Pergola, G., et al. (2023) · Nutrients · doi:10.3390/nu16010063 · Cited by 101
Deranged Myocardial Fatty Acid Metabolism in Heart Failure
Yamamoto, T., & Sano, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020996 · Cited by 112
“In the diabetic heart, impaired glucose metabolism is observed mainly due to impaired insulin signaling caused by IRS inhibition [25].”
BackgroundGuo, F., Gong, Z., Fernando, T., Zhang, L., Zhu, X., & Shi, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.892125 · Cited by 126
“At the same time, increased accumulation of FFAs and their metabolite in the adipocyte led to ectopic lipid accumulation (41) and insulin resistance in the liver (42).”
BackgroundThe Role of microRNAs in Metabolic Syndrome-Related Oxidative Stress
Włodarski, A., Strycharz, J., Wróblewski, A. M., Kasznicki, J., Drzewoski, J., & Śliwińska, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186902 · Cited by 107
“Moreover, lipogenesis and gluconeogenesis become promoted [92,305].”
BackgroundYaribeygi, H., Butler, A. E., Barreto, G. E., & Sahebkar, A. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27278 · Cited by 104
“Insulin is a hypoglycemic hormone that is released in a glucose‐ responsive manner by pancreatic beta cells and which facilitates the transport of glucose into the muscular, hepatic and lipid cells via GLUT‐4 (glucose transporter type 4; Samuel & Shulman, 2016).”
BackgroundWang, Q., Jokelainen, J. J., AUVINEN, J. P., Puukka, K. S., Keinanen-Kiukaanniemi, S. M., Järvelin, M., Kettunen, J., Mäkinen, V., & Ala‐Korpela, M. (2019) · BMC Medicine · doi:10.1186/s12916-019-1440-4 · Cited by 109
Crosstalk between nonalcoholic fatty liver disease and cardiometabolic syndrome
Lim, S. K., Taskinen, M., & Borén, J. (2018) · Obesity Reviews · doi:10.1111/obr.12820 · Cited by 111
“Thus, fatty acid accumulation in the liver induces insulin resistance, which contributes to increases in endogenous glucose production.(79) This acts as a stimulus for further increased whole‐body insulin resistance, leading to accelerated atherosclerosis.”
BackgroundAlzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
Rojas, M., Chávez-Castillo, M., Bautista, J., Ortega, Á., Nava, M., Salazar, J., Díaz-Camargo, E., Medina, O., Rojas-Quintero, J., & Bermúdez, V. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i6.745 · Cited by 94
O-GlcNAc transferase inhibits visceral fat lipolysis and promotes diet-induced obesity
Yang, Y., Fu, M., Li, M., Zhang, K., Zhang, B., Wang, S., Liu, Y., Ni, W., Ong, Q., Mi, J. D., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13914-8 · Cited by 110
Excess Accumulation of Lipid Impairs Insulin Sensitivity in Skeletal Muscle
Park, S. S., & Seo, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21061949 · Cited by 118
“Maintaining metabolic homeostasis involves the concerted communication efforts of multiple tissues including the digestive system, pancreas, and adipose and muscle tissues [1].”
BackgroundTracing insights into de novo lipogenesis in liver and adipose tissues
Wallace, M., & Metallo, C. M. (2020) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2020.02.012 · Cited by 107
G0S2: A small giant controller of lipolysis and adipose-liver fatty acid flux
Zhang, X., Heckmann, B. L., Campbell, L. E., & Liu, J. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2017.06.007 · Cited by 93
“As a result, whole-body and tissue-specific insulin sensitivity can be negatively affected [13, 14].”
BackgroundGong, M., Wen, S., Nguyen, T., Wang, C., Jin, J., & Zhou, L. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s232377 · Cited by 92
Hepatic ketogenic insufficiency reprograms hepatic glycogen metabolism and the lipidome
d’Avignon, D. A., Puchalska, P., Ercal, B., Chang, Y., Martin, S. E., Graham, M. J., Patti, G. J., Han, X., & Crawford, P. A. (2018) · JCI Insight · doi:10.1172/jci.insight.99762 · Cited by 90
Wen, J., Wang, A., Liu, G., Wang, M., Zuo, Y., Li, W., Zhai, Q., Mu, Y., Gaisano, H. Y., He, Y., et al. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01401-9 · Cited by 94
“Glycerol and fatty acids are two products of TG lipolysis can enhance liver gluconeogenesis [34, 35].”
BackgroundDadmanesh, M., Aghajani, H., Fadaei, R., & Ghorban, K. (2018) · PLOS ONE · doi:10.1371/journal.pone.0204180 · Cited by 89
Recent advances in managing/understanding the metabolic syndrome
Aguilar-Salinas, C. A., & Viveros-Ruiz, T. L. (2019) · F1000Research · doi:10.12688/f1000research.17122.1 · Cited by 97
Tian, B., Zhao, J., Xie, X., Chen, T., Yin, Y., Zhai, R., Wang, X., An, W., & Li, J. (2021) · Food & Function · doi:10.1039/d0fo02936j · Cited by 92
Liu, D., Yang, K., Gu, H., Li, Z., Wang, Y., & Wang, Y. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01704-4 · Cited by 88
“First, TyG index can reflect the glucose metabolism, inflammation and oxidative stress in the body; Second, TyG index can reflect the metabolism of glycosylation products, oxygen radical, nitric oxide (NO) and platelet reactivity, which can lead to endothelial cell-dependent vasodilation [40].”
BackgroundObesity-Driven Metabolic Disorders: The Interplay of Inflammation and Mitochondrial Dysfunction
Choi, W., Woo, G. H., Kwon, T., & Jeon, J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26199715 · Cited by 135
“In particular, DAG accumulation in muscle can activate novel PKC isoforms (e.g., PKC θ ), which then phosphorylate and inhibit insulin receptor signaling, while ceramides may antagonize insulin action by impairing Akt phosphorylation [55,56].”
Hepatic Insulin Resistance Is Not Pathway Selective in Humans With Nonalcoholic Fatty Liver Disease
ter Horst, K. W., Vatner, D. F., Zhang, D., Cline, G. W., Ackermans, M. T., Nederveen, A. J., Verheij, J., Demirkiran, A., van Wagensveld, B. A., Dallinga-Thie, G. M., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1644 · Cited by 88
Self-citationMechanisms by which a Very-Low-Calorie Diet Reverses Hyperglycemia in a Rat Model of Type 2 Diabetes
Perry, R. J., Peng, L., Cline, G. W., Wang, Y., Rabin-Court, A., Song, J. D., Zhang, D., Zhang, X.-M., Nozaki, Y., Dufour, S., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2017.10.004 · Cited by 88
“The key question, then, becomes: how does short-term VLCD reverse T2D prior to clinically significant weight loss? Given the key roles of ectopic lipid and increased rates of hepatic glucose production in promoting hepatic insulin resistance and fasting hyperglycemia in T2D (Perry et al., 2014; Samuel and Shulman, 201…”
Self-citationTargher, G., Marchesini, G., & Byrne, C. D. (2016) · Diabetes & Metabolism · doi:10.1016/j.diabet.2016.04.002 · Cited by 98
Immunologic impact of the intestine in metabolic disease
Winer, D. A., Winer, S., Dranse, H. J., & Lam, T. K. T. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88879 · Cited by 86
Lipometabolism and Glycometabolism in Liver Diseases
Ding, H., Wang, J., Ren, H., & Shi, X. (2018) · BioMed Research International · doi:10.1155/2018/1287127 · Cited by 96
“Acetyl-CoA is a strong activator of pyruvate carboxylase, which can promote the transformation of glycerol to glucose known as gluconeogenesis [13].”
BackgroundPathogenesis of Insulin Resistance and Atherogenic Dyslipidemia in Nonalcoholic Fatty Liver Disease
Akhtar, D. H., Iqbal, U., Vazquez‐Montesino, L. M., Dennis, B. B., & Ahmed, A. (2019) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2019.00028 · Cited by 105
“Insulin resistance plays a major role in the development of atherogenic dyslipidemia in NAFLD and the subsequent development of premature CVD.(10) In this article, we will review the role of insulin in hepatic glucose and lipid metabolism, the mechanisms that may lead to NAFLDrelated dyslipidemia and ectopic lipid dep…”
BackgroundInfluentialER stress as a sentinel mechanism for ER Ca2+ homeostasis
Makio, T., Chen, J., & Simmen, T. (2024) · Cell Calcium · doi:10.1016/j.ceca.2024.102961 · Cited by 94
Petersen, K. F., Befroy, D. E., Dufour, S., Rothman, D. L., & Shulman, G. I. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.06.005 · Cited by 84
“Non-alcoholic fatty liver disease (NAFLD) currently affects one in three Americans and is amajor predisposing factor in the path- ogenesis of type 2 diabetes (T2D) (Samuel and Shulman, 2016).”
BackgroundInfluentialSelf-citationMarino, J. S., Stechschulte, L. A., Stec, D. E., Nestor‐Kalinoski, A. L., Coleman, S., & Hinds, T. D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752311 · Cited by 94
“4D), consistent with our previous findings (26).”
BackgroundRoles of pyruvate carboxylase in human diseases: from diabetes to cancers and infection
Lao-On, U., Attwood, P. V., & Jitrapakdee, S. (2018) · Journal of Molecular Medicine · doi:10.1007/s00109-018-1622-0 · Cited by 94
“High levels of hepatic acetyl-CoA in turn allosterically activate PC activity, increasing the rate of hepatic glucose production [12, 22].”
BackgroundBeyond the X Factor: Relevance of Sex Hormones in NAFLD Pathophysiology
Torre, S. D. (2021) · Cells · doi:10.3390/cells10092502 · Cited by 101
Hashiesh, H. M., Sharma, C., Goyal, S. N., Sadek, B. S., Jha, N. K., Kaabi, J. A., & Ojha, S. K. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111639 · Cited by 112
PI3K signaling-regulated metabolic reprogramming: From mechanism to application
Su, W. Y., Tian, L. Y., Guo, L. P., Huang, L., & Gao, W. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188952 · Cited by 96
The Activation Mechanism of the Insulin Receptor: A Structural Perspective
Choi, E., & Bai, X. (2023) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-052521-033250 · Cited by 95
Hashiesh, H. M., Meeran, M. F. N., Sharma, C., Sadek, B. S., Kaabi, J. A., & Ojha, S. K. (2020) · Nutrients · doi:10.3390/nu12102963 · Cited by 95
Truong, X. T., & Lee, D. H. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0644 · Cited by 84
“Supporting this perspective, monosaccharides have been shown to activate ChREBP and other key lipogenic transcription factors—including SREBP1c, LXR, and PPARγ—via insulin-independent mechanisms [34,70,83,86,99].”
Stem-cell based organ-on-a-chip models for diabetes research
Rogal, J., Zbinden, A., Schenke‐Layland, K., & Loskill, P. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.010 · Cited by 93
Pavlíková, N., Daniel, P., Šrámek, J., Jelínek, M., Šrámková, V., Němcová‐Fürstová, V., Balušíková, K., Halada, P., & Kovár̆, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-54579-z · Cited by 79
Li, Y., Gao, S., Shi, S., Xiao, D., Peng, S., Gao, Y., Zhu, Y. J., & Lin, Y. (2021) · Nano-Micro Letters · doi:10.1007/s40820-021-00614-6 · Cited by 91
Li, H., Dun, Y., Zhang, W., You, B., Liu, Y., Fu, S., Qiu, L., Cheng, J., Ripley-Gonzalez, J. W., & Liu, S. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119314 · Cited by 80
Gao, S., Ghoshal, S., Zhang, L., Stevens, J. R., McCommis, K. S., Finck, B. N., Lopaschuk, G. D., & Butler, A. A. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.008967 · Cited by 80
“S3A), an allosteric regulator of PC activity (8, 18).”
BackgroundInfluentialOGT suppresses S6K1-mediated macrophage inflammation and metabolic disturbance
Yang, Y., Li, X., Luan, H. H., Zhang, B., Zhang, K., Nam, J. H., Li, Z., Fu, M., Munk, A., Zhang, D., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1916121117 · Cited by 81
“Ectopic lipid accumulation is closely associated with insulin resistance (1, 46).”
BackgroundSelf-citationIvashkin, V. T., Maevskaya, M. V., Жаркова, М. С., Kotovskaya, Y. V., Ткачева, О. Н., Troshina, E. A., Shestakova, M. V., Maev, I. V., Breder, V. V., Geyvandova, N. I., et al. (2022) · Russian Journal of Gastroenterology Hepatology Coloproctology · doi:10.22416/1382-4376-2022-32-4-104-140 · Cited by 101
Kodavanti, U. P. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.05.010 · Cited by 83
Vatner, D. F., Goedeke, L., Camporez, J.-P. G., Lyu, K., Nasiri, A. R., Zhang, D., Bhanot, S., Murray, S. F., Still, C. D., Gerhard, G. S., et al. (2018) · Diabetologia · doi:10.1007/s00125-018-4579-1 · Cited by 76
“(f) Hepatic Akt phosphorylation, comparing basal (B) 6 h fasted livers with clamped (C) insulin-stimulated livers.”
BackgroundSelf-citationGoedeke, L., Perry, R. J., & Shulman, G. I. (2019) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104727 · Cited by 77
Self-citationSmall, L., Brandon, A. E., Turner, N., & Cooney, G. J. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00337.2017 · Cited by 72
“Clearly, our understanding of the mechanisms involved in diet-induced, skeletal muscle insulin resistance remains incomplete despite the detailed analysis of the molecular mechanisms involved in skeletal muscle insulin action outlined in several review articles (1, 43, 69, 103, 142, 143, 177).”
BackgroundThe Impact of Obesity on Microglial Function: Immune, Metabolic and Endocrine Perspectives
Alexaki, V. I. (2021) · Cells · doi:10.3390/cells10071584 · Cited by 71
Insulin and cancer: a tangled web
Leitner, B. P., Siebel, S., Akingbesote, N. D., Zhang, X., & Perry, R. J. (2022) · Biochemical Journal · doi:10.1042/bcj20210134 · Cited by 84
Zheng, J., Xiao, X., Zhang, Q., Wang, T., Yu, M., & Xu, J. (2017) · Nutrients · doi:10.3390/nu9030205 · Cited by 78
Zheng, D., Dou, J., Liu, G., Pan, Y., Yan, Y., Liu, F., Gaisano, H. Y., Lu, J., & He, Y. L. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01656 · Cited by 88
“is a potent activator of pyruvate carboxylase, a critical ratelimiting enzyme in gluconeogenesis (40, 41).”
BackgroundHuang, X., Yao, Y., Hou, X., Wei, L., Rao, Y., Su, Y., Zheng, G., Ruan, X. Z., Li, D., & Chen, Y. (2022) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2022.03.006 · Cited by 70
“adipocyte lipolysis is dysregulated, lipids can accumulate in ectopic tissues such as the liver, leading to insulin insensitivity and NAFLD.(36) Lipodystrophy is associated with an inflammatory environment, especially inflammatory factors released by activated macrophages, which stimulate lipolysis by increasing the e…”
BackgroundMatar, D. B., Zhra, M., Nassar, W. K., Altemyatt, H., Naureen, A., Abotouk, N., Elahi, M. A., & Aljada, A. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1592683 · Cited by 105
Deregulated Lysophosphatidic Acid Metabolism and Signaling in Liver Cancer
Kaffe, E., Magkrioti, C., & Aidinis, V. (2019) · Cancers · doi:10.3390/cancers11111626 · Cited by 73
Xu, D., Guo, X., Zeng, Z., Wang, Y., & Qiu, J. Y. (2021) · Food & Function · doi:10.1039/d0fo02761h · Cited by 78
Pranata, R., Huang, I., Irvan, I., Lim, M. A., & Vania, R. (2021) · Endocrine · doi:10.1007/s12020-021-02780-4 · Cited by 81
Nachit, M., & Leclercq, I. A. (2019) · Clinical Science · doi:10.1042/cs20180421 · Cited by 73
Sharma, A., Oonthonpan, L., Sheldon, R. D., Rauckhorst, A. J., Zhu, Z., Tompkins, S. C., Cho, K., Grzesik, W. J., Gray, L. R., Scerbo, D. A., et al. (2019) · eLife · doi:10.7554/elife.45873 · Cited by 73
“Similarly, during obesity and T2D chronically elevated muscle lipid content and insulin resistance strongly associate, with increased ceramides, diacylglycerols, and mitochondrial acyl-carnitines and -CoAs implicated as causing insulin resistance (Koves et al., 2008; Samuel and Shulman, 2016).”
BackgroundIrisin reverses insulin resistance in C2C12 cells via the p38-MAPK-PGC-1α pathway
Ye, X., Shen, Y., Ni, C., Ye, J., Xin, Y., Zhang, W., & Ren, Y. (2019) · Peptides · doi:10.1016/j.peptides.2019.170120 · Cited by 72
Altered glucose metabolism and insulin resistance in cancer-induced cachexia: a sweet poison
Masi, T., & Patel, B. M. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00179-y · Cited by 80
“β-oxidation of NEFA yields acetyl-CoA in mitochondria [101].”
BackgroundThe RISE Consortium* (2019) · Diabetes · doi:10.2337/db19-0299 · Cited by 72
“It is plausible that the pathophysiology of dysglycemia in youth is driven by more severe hepatic and adipose tissue insulin resistance, both of which are potentially related to the obesity and the co-occurrence of fatty liver (21,22).”
BackgroundThe roles of dietary lipids and lipidomics in gut-brain axis in type 2 diabetes mellitus
Ağagündüz, D., İçer, M. A., Yeşildemir, Ö., Koçak, T., Koçyiğit, E., & Capasso, R. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04088-5 · Cited by 89
“resistance, which directs ingested glucose to the liver, increasing hepatic de novo lipogenesis and hyperlipidemia [124].”
BackgroundThe Impact of Adipose Tissue on Insulin Resistance in Acromegaly
Olarescu, N. C., & Bollerslev, J. (2016) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2016.02.005 · Cited by 79
“, diacylglycerols) in muscle and liver induces the activation of a novel protein kinase C pathwaywith subsequent impairments in insulin signaling [15,26,27].”
BackgroundCamporez, J. P., Lyu, K., Goldberg, E. L., Zhang, D., Cline, G. W., Jurczak, M. J., Dixit, V. D., Petersen, K. F., & Shulman, G. I. (2019) · The Journal of Physiology · doi:10.1113/jp277270 · Cited by 71
“…Society ectopic lipid accumulation and hepatic and muscle insulin resistance (Cantley et al. 2013; Camporez et al. 2015, 2017; Petersen et al. 2016; Samuel & Shulman, 2016; Abulizi et al. 2017), and our data clearly showed this association between reduced ectopic lipid content (DAG in particular)…”
BackgroundSelf-citationRole of macrophages in the endocrine system
Rehman, A., Pacher, P., & Haskó, G. (2021) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2020.12.001 · Cited by 71
Ghaffari, S., Abbasi, A., Somi, M. H., Moaddab, S. Y., Nikniaz, L., Kafil, H. S., & Leylabadlo, H. E. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2045894 · Cited by 88
“The diminished synthesis and transport of fatty acid in the liver and muscles after supplementation with A. muciniphila was ascribed to increased activation of insulin signals (Samuel and Shulman 2016).”
BackgroundAn, H., Jang, Y., Choi, J.-I., Hur, J., Kim, S., & Kwon, Y. (2024) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2024.188 · Cited by 80
Mechanisms of sleep deprivation-induced hepatic steatosis and insulin resistance in mice
Shigiyama, F., Kumashiro, N., Tsuneoka, Y., Igarashi, H., Yoshikawa, F., Kakehi, S., Funato, H., & Hirose, T. (2018) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00072.2018 · Cited by 77
“gluconeogenic function of pyruvate carboxylase (44, 50).”
BackgroundSleep, Health, and Metabolism in Midlife Women and Menopause
Kravitz, H. M., Kazlauskaite, R., & Joffe, H. (2018) · Obstetrics and Gynecology Clinics of North America · doi:10.1016/j.ogc.2018.07.008 · Cited by 90
De Novo Lipogenesis Products and Endogenous Lipokines
Yilmaz, M., Claiborn, K. C., & Hotamışlıgil, G. S. (2016) · Diabetes · doi:10.2337/db16-0251 · Cited by 78
“It is important to note that lipid accumulation in the liver per se is not universally associated with adverse outcomes, and several different mechanistic models have been proposed to underlie these events (6).”
Coco, L. D., Vergara, D., Matteis, S. D., Mensa’, E., Sabbatinelli, J., Prattichizzo, F., Bonfigli, A. R., Storci, G., Bravaccini, S., Pirini, F., et al. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8050720 · Cited by 73
“Considering that impaired fatty acid transport inside mitochondria can result in triglyceride cytosolic accumulation in and IR [69], we can consider the reduced serum carnitine level measured in complicated T2DM patients closely associated to the highest HOMA-IR of these subjects.”
BackgroundThe Lymphatic System in Obesity, Insulin Resistance, and Cardiovascular Diseases
Jiang, X., Tian, W., Nicolls, M. R., & Rockson, S. G. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.01402 · Cited by 78
“In aggregate, the net effect of high concentrations of leptin on lymphangiogenesis appears to be suppressive (Sato et al., 2016).”
Background
Metadata
- Authors
- Samuel, V. T., & Shulman, G. I.
- Affiliations
- Veterans Health Administration (US)
- Howard Hughes Medical Institute (US)
- Venue
- Journal of Clinical Investigation
- Published
- 2016-01-04
- Volume
- 126
- Issue
- 1
- Pages
- 12-22
- ISSN
- 0021-9738 (ISSN-L)
- 1558-8238
- PMC
- PMC4701542
- OpenAlex
- W2230222215
- Cited by
- 1,484
- References
- 131
- Citations by year
- 2026: 192 · 2025: 162 · 2024: 152 · 2023: 150 · 2022: 150 · 2021: 143 · 2020: 134 · 2019: 136 · 2018: 114 · 2017: 99 · 2016: 51
- FWCI
- 18.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs (I01 BX000901)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-49230, R01DK049230, DK40936, DK 45735, R01DK040936, U24DK059635, R24DK085638, DK059635, DK-085638, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Keywords
- insulin resistance, type 2 diabetes, ectopic fat deposition, hepatic insulin signaling, skeletal muscle glucose uptake, hepatic gluconeogenesis, hepatic de novo lipogenesis, adipose tissue lipolysis, hepatic triglyceride synthesis, fatty acid esterification, hyperlipidemia, hyperglycemia, pyruvate carboxylase, acetyl-CoA, substrate flux, inflammation, energy surplus
- MeSH terms
- Adipose Tissue, Animals, Glucose, Humans, Insulin Resistance, Liver, Triglycerides, Signal Transduction, Muscle, Skeletal, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.